Autolus Therapeutics plc (6A3A) — Financial Flexibility Index
Autolus Therapeutics plc (6A3A) has a Financial Flexibility Index of -0.06x as of June 2026. Free cash flow of €-24.16 Million (operating CF €-25.07 Million minus capex €913.00K) represents 0% of total liabilities (€418.39 Million). Check Autolus Therapeutics plc tangible equity quality to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Autolus Therapeutics plc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Autolus Therapeutics plc across 9 annual periods. For the full cash flow conversion analysis, see Autolus Therapeutics plc (6A3A) cash conversion ratio.
Annual Financial Flexibility Index for Autolus Therapeutics plc (2017–2025)
Year-by-year free cash flow to debt coverage for Autolus Therapeutics plc. Explore Autolus Therapeutics plc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.62x | €-256.44 Million | €-283.57 Million | €410.94 Million | ▼ -29.4% |
| 2024 | -0.48x | €-171.45 Million | €-206.27 Million | €355.40 Million | ▲ +5.4% |
| 2023 | -0.51x | €-134.60 Million | €-145.59 Million | €263.91 Million | ▲ +3.7% |
| 2022 | -0.53x | €-101.47 Million | €-112.31 Million | €191.60 Million | ▲ +55.2% |
| 2021 | -1.18x | €-109.00 Million | €-117.86 Million | €92.24 Million | ▲ +3.5% |
| 2020 | -1.22x | €-103.08 Million | €-117.76 Million | €84.20 Million | ▲ +28.3% |
| 2019 | -1.71x | €-83.14 Million | €-101.48 Million | €48.69 Million | ▼ -1.8% |
| 2018 | -1.68x | €-29.75 Million | €-42.52 Million | €17.74 Million | ▲ +24.6% |
| 2017 | -2.22x | €-13.48 Million | €-16.36 Million | €6.06 Million | — |